facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2009
vol. 96
 
Share:
Share:
abstract:
Original paper

Grover’s disease – a diagnostic and therapeutic challenge

Wioletta Barańska-Rybak
,
Igor Michajłowski
,
Agata Maciejewska-Radomska
,
Małgorzata Sokołowska-Wojdyło

Przegl Dermatol 2009, 96, 287–292
Online publish date: 2009/09/01
View full text Get citation
 
Introduction. Grover’s disease is a transient acantholytic dermatosis of unknown origin. It is a pruritic, papulovesicular eruption characterized histopathologically by acantholysis with or without dyskeratosis. The disease has occasionally been reported in patients with chronic renal failure, HIV infection and after bone marrow allotransplantation.
Objective. Presentation of a case of Grover disease recalcitrant to standard therapy.
Case report. A 66-yr-old male patient was admitted to our department with a 3-month history of disseminated, itchy, papular eruption on the trunk. His general condition was satisfactory. The patient was treated previously with antihistamines and topical corticosteroids with no effect. Laboratory examinations were within normal limits. In histopathology acantholytic and dyskerototic changes in the epidermis consistent with Grover’s disease were observed. The patient was treated with oral acitretin and topical corticosteroids without improvement. Skin lesions and pruritus subsided after 8 weeks of treatment with the Re-PUVA method.
Conclusions. In cases of Grover’s disease resistant to standard therapies (emollients, topical corticosteroids) introduction of Re-PUVA treatment may have a beneficial effect.
keywords:

Grover’s disease, acantholytic dermatosis, phototherapy, retinoids



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.